Angiotensin II for the Treatment of Vasodilatory Shock

K. Khanna, Ashish; English, Shane; S. Wang, Xueyuan; R. Ham, Kealy; A. Tumlin, James; M. Szerlip, Harold; W. Busse, Laurence; Altaweel, Laith; E. Albertson, Timothy; Mackey, Caleb; T. McCurdy, Michael; W. Boldt, David; Chock, Stefan; J. Young, Paul; Krell, Kenneth; G. Wunderink, Richard; Ostermann, Marlies; Murugan, Raghavan; N. Gong, Michelle; Panwar, Rakshit; Hästbacka, Johanna; Favory, Raphaël; Venkatesh, Balasubramanian; Thompson, Bruce; Bellomo, Rinaldo; Jensen, Jeffrey; Kroll, Stew; S. Chawla, Lakhmir; F. Tidmarsh, George; M. Deane, Adam

doi:10.1056/nejmoa1704154

Public

Angiotensin II for the Treatment of Vasodilatory Shock

Published in New England Journal of Medicine • May 21, 2017

Authors:

Ashish K. Khanna

Shane English

Xueyuan S. Wang

Abstract

BACKGROUND: Vasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. We investigated the effectiveness of angiotensin II for the treatment of patients with this condition. METHODS: We randomly assigned patients with vasodilatory shock who were receiving m...

Subject

Medicine

Vasodilation

Angiotensin II

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!